Dr. Bruce Patterson has a notable history with the biotechnology company CytoDyn, which developed the drug leronlimab. Their relationship has been marked by both collaboration and conflict:

Consulting and Advocacy: Dr. Patterson served as a consultant for CytoDyn. He also became a vocal advocate for leronlimab, particularly for its potential in treating long COVID and other conditions, based on his own research.

Activist Investor Group: Dr. Patterson led a group of activist shareholders in an attempt to take over CytoDyn's board of directors. The group accused the company's leadership of mishandling the development of leronlimab and sought to implement a new strategic plan.


Conflict of Interest Allegations: CytoDyn, in turn, accused Dr. Patterson of having a conflict of interest. The company alleged that Patterson's group was trying to force CytoDyn to acquire IncellDx, a company he founded and of which he and his wife owned a significant portion.